-
Je něco špatně v tomto záznamu ?
Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs
K. Meskova, K. Martonova, P. Hrasnova, K. Sinska, M. Skrabanova, L. Fialova, S. Njemoga, O. Cehlar, O. Parmar, P. Kolenko, V. Pevala, R. Skrabana
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
APVV-21-0479, APVV-20-0513
Slovak Research and Development Agency
2/0152/21, 2/0141/23, 2/0125/23
VEGA
NLK
Directory of Open Access Journals
od 2012
PubMed Central
od 2016
Europe PubMed Central
od 2016
ProQuest Central
od 2012-03-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
37606435
DOI
10.3390/antib12030051
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Laboratory production of recombinant mammalian proteins, particularly antibodies, requires an expression pipeline assuring sufficient yield and correct folding with appropriate posttranslational modifications. Transient gene expression (TGE) in the suspension-adapted Chinese Hamster Ovary (CHO) cell lines has become the method of choice for this task. The antibodies can be secreted into the media, which facilitates subsequent purification, and can be glycosylated. However, in general, protein production in CHO cells is expensive and may provide variable outcomes, namely in laboratories without previous experience. While achievable yields may be influenced by the nucleotide sequence, there are other aspects of the process which offer space for optimization, like gene delivery method, cultivation process or expression plasmid design. Polyethylenimine (PEI)-mediated gene delivery is frequently employed as a low-cost alternative to liposome-based methods. In this work, we are proposing a TGE platform for universal medium-scale production of antibodies and other proteins in CHO cells, with a novel expression vector allowing fast and flexible cloning of new genes and secretion of translated proteins. The production cost has been further reduced using recyclable labware. Nine days after transfection, we routinely obtain milligrams of antibody Fabs or human lactoferrin in a 25 mL culture volume. Potential of the platform is established based on the production and crystallization of antibody Fabs and their complexes.
AXON Neuroscience R and D Services SE 811 02 Bratislava Slovakia
Faculty of Natural Sciences Comenius University 842 15 Bratislava Slovakia
Institute of Molecular Biology Slovak Academy of Sciences 845 51 Bratislava Slovakia
Institute of Neuroimmunology Slovak Academy of Sciences 845 10 Bratislava Slovakia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015522
- 003
- CZ-PrNML
- 005
- 20250923164533.0
- 007
- ta
- 008
- 231010s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/antib12030051 $2 doi
- 035 __
- $a (PubMed)37606435
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Meskova, Klaudia $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u Faculty of Natural Sciences, Comenius University, 842 15 Bratislava, Slovakia
- 245 10
- $a Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs / $c K. Meskova, K. Martonova, P. Hrasnova, K. Sinska, M. Skrabanova, L. Fialova, S. Njemoga, O. Cehlar, O. Parmar, P. Kolenko, V. Pevala, R. Skrabana
- 520 9_
- $a Laboratory production of recombinant mammalian proteins, particularly antibodies, requires an expression pipeline assuring sufficient yield and correct folding with appropriate posttranslational modifications. Transient gene expression (TGE) in the suspension-adapted Chinese Hamster Ovary (CHO) cell lines has become the method of choice for this task. The antibodies can be secreted into the media, which facilitates subsequent purification, and can be glycosylated. However, in general, protein production in CHO cells is expensive and may provide variable outcomes, namely in laboratories without previous experience. While achievable yields may be influenced by the nucleotide sequence, there are other aspects of the process which offer space for optimization, like gene delivery method, cultivation process or expression plasmid design. Polyethylenimine (PEI)-mediated gene delivery is frequently employed as a low-cost alternative to liposome-based methods. In this work, we are proposing a TGE platform for universal medium-scale production of antibodies and other proteins in CHO cells, with a novel expression vector allowing fast and flexible cloning of new genes and secretion of translated proteins. The production cost has been further reduced using recyclable labware. Nine days after transfection, we routinely obtain milligrams of antibody Fabs or human lactoferrin in a 25 mL culture volume. Potential of the platform is established based on the production and crystallization of antibody Fabs and their complexes.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Martonova, Katarina $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u Faculty of Natural Sciences, Comenius University, 842 15 Bratislava, Slovakia
- 700 1_
- $a Hrasnova, Patricia $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia
- 700 1_
- $a Sinska, Kristina $u AXON Neuroscience R&D Services SE, 811 02 Bratislava, Slovakia
- 700 1_
- $a Skrabanova, M. $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $7 xx0335110
- 700 1_
- $a Fialova, Lubica $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u AXON Neuroscience R&D Services SE, 811 02 Bratislava, Slovakia
- 700 1_
- $a Njemoga, Stefana $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $u Faculty of Natural Sciences, Comenius University, 842 15 Bratislava, Slovakia
- 700 1_
- $a Cehlar, Ondrej $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $1 https://orcid.org/0000000219966812
- 700 1_
- $a Parmar, Olga $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia
- 700 1_
- $a Kolenko, Petr $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, 115 19 Prague, Czech Republic
- 700 1_
- $a Pevala, Vladimir $u Institute of Molecular Biology, Slovak Academy of Sciences, 845 51 Bratislava, Slovakia $1 https://orcid.org/0000000151108837
- 700 1_
- $a Skrabana, Rostislav $u Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia $1 https://orcid.org/0000000182005275
- 773 0_
- $w MED00213964 $t Antibodies $x 2073-4468 $g Roč. 12, č. 3 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37606435 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20250923164529 $b ABA008
- 999 __
- $a ok $b bmc $g 1997169 $s 1201884
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 12 $c 3 $e 20230804 $i 2073-4468 $m Antibodies $n Antibodies $x MED00213964
- GRA __
- $a APVV-21-0479, APVV-20-0513 $p Slovak Research and Development Agency
- GRA __
- $a 2/0152/21, 2/0141/23, 2/0125/23 $p VEGA
- LZP __
- $a Pubmed-20231010